A 35-year-old man with severe TEN (45% body surface area involvement) presents with fever, mucosal ulceration, and rapidly progressive skin necrosis 4 days after starting phenytoin for seizure prophylaxis. The offending drug has been discontinued. Despite aggressive supportive care over 48 hours, the rash continues to spread and new lesions are appearing. Which agent should now be added to the management regimen?